Vaccine Diluent Improvement for ECF-ITM

点击翻译按钮获取中文摘要

This project represents a unique opportunity to translate British technology and expertise from thehuman health sector into livestock disease control in the developing world context. The project focuseson East Coast Fever (ECF), a major constraint on small-holder cattle production in East, Central andSouthern Africa. An effective vaccine, ECF-ITM, currently exists for the disease but it has a number ofimportant drawbacks that affects its use in the field. This project will trial the use of novel formulationsas a replacement for the ECF-ITM vaccine diluent. Success in the project will deliver important ECF-ITMvaccine product enhancements, notably vaccine stability. This will afford far greater mobility andflexibility to ECF vaccinators resulting in an estimated 300,000 additional cattle being effectivelyimmunised per year. This will be a notable development in the sustainable intensification of small-holder cattle production in the region.Finance summary tableTo assist the applicant with the Finance Section of this application form please refer to the Guidance for Applicants. It will